CAR T-Cells: Promise and Peril of Cancer’s Silver Bullet – UNIT SCIENTIFIC
$100M for Tmunity cancer gene therapy from China, U.S. investors
Joseph N. DiStefano, Staff Writer
Updated: Tuesday, January 23, 2018, 9:31 AM
Tmunity Therapeutics, a Philadelphia for-profit company set up by cancer-fighting Dr. Carl June and his colleagues at the University of Pennsylvania, says it has raised $100 million from China- and U.S.-based investors to speed development of its T-cell-based personal cancer treatments.